欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/3985/001
药品名称Everolimus Synthon Hispania 2,5 mg, tablets
活性成分
    • everolimus 2.5 mg
剂型Tablet
上市许可持有人Accord Healthcare Limited Sage House, 319 Pinner Road HA1 4HF North Harrow, Middlesex United Kingdom
参考成员国 - 产品名称Netherlands (NL)
Everolimus Synthon Hispania 2,5 mg, tabletten
互认成员国 - 产品名称
    • Hungary (HU)
    • Czechia (CZ)
      Everolimus Accord 2.5 mg tablety
    • Romania (RO)
    • Slovakia (SK)
    • Germany (DE)
      Everolimus Synthon Hispania 2,5 mg Tabletten
    • United Kingdom (Northern Ireland) (XI)
    • Italy (IT)
    • Poland (PL)
      Everolimus Accord
许可日期2018/05/30
最近更新日期2024/04/04
药物ATC编码
    • L01XE10 everolimus
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Multiple (Copy) Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase